![Thomas Schall](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Schall
Président chez
IMMUNEERING CORPORATION
Fortune : 371 905 $ au 30/06/2026
Profil
Thomas J.
Schall was the founder of ChemoCentryx, Inc., founded in 1997, where the titles held included Chairman, President & Chief Executive Officer from 2012 to 2022.
The current job is Chairman at Immuneering Corp., starting in 2025.
Former jobs include Scientist at Genentech, Inc., and Principal at DNAX Research, Inc. from 1993 to 1997.
Education includes a doctorate from Stanford University and an undergraduate degree from Northern Illinois University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 11/06/2026 | 74 530 ( 0,12 % ) | 371 905 $ | 30/06/2026 |
Postes actifs de Thomas Schall
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNEERING CORPORATION | Président | 16/09/2025 |
Anciens postes connus de Thomas Schall
| Sociétés | Poste | Fin |
|---|---|---|
| CHEMOCENTRYX, INC. | Directeur Général | 20/10/2022 |
DNAX Research, Inc. | Corporate Officer/Principal | 01/01/1997 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Directeur Technique/Scientifique/R&D | - |
Formation de Thomas Schall
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northern Illinois University
 Northern Illinois University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
DNAX Research, Inc. | |
Immuneering Corp.
 Immuneering Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company, focuses on the oncology and neuroscience product candidates | Health Technology |
